Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Will Late Loss Debate Stifle Device Start-Up Innovation?

This article was originally published in Start Up

Executive Summary

The failure of Medtronic's Endeavor stent to hit its primary clinical trial endpoint has again spurred debate over surrogate endpoints, a potentially big issue for small companies.

You may also be interested in...



The Double-edged Sword of Diabetes Drug Development

Intense interest in new diabetes drugs gives start-ups many choices for technology development or in-licensing, but recent regulatory caution also increases risk.

View From the Cath Lab: Hot Issues in Cardiology

Three leading interventional cardiologists provide international perspectives on the most important issues confronting their specialty and how they will impact the device industry.

QUOTED. 22 January 2020. Steve Niedelman.

Steve Niedelman of the law firm King & Spalding gave manufacturers a few words of advice when prepping their so-called front rooms, where US FDA investigators do the majority of their work during facility inspections. See what he said here.

Topics

Related Companies

UsernamePublicRestriction

Register

MT037340

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel